Jeffrey V. Poulton
2019
In 2019, Jeffrey V. Poulton earned a total compensation of $5.9M as Executive Vice President, Chief Financial Officer principal financial officer at Alnylam Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $136,740 |
|---|---|
| Option Awards | $5,479,525 |
| Salary | $254,808 |
| Other | $6,343 |
| Total | $5,877,416 |
Poulton received $5.5M in option awards, accounting for 93% of the total pay in 2019.
Poulton also received $136.7K in non-equity incentive plan, $254.8K in salary and $6.3K in other compensation.
Rankings
In 2019, Jeffrey V. Poulton's compensation ranked 1,766th out of 13,971 executives tracked by ExecPay. In other words, Poulton earned more than 87.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,766 out of 13,971 | 87th |
Division Manufacturing | 627 out of 5,701 | 89th |
Major group Chemicals And Allied Products | 187 out of 2,200 | 92nd |
Industry group Drugs | 150 out of 1,886 | 92nd |
Industry Pharmaceutical Preparations | 112 out of 1,398 | 92nd |
Source: SEC filing on April 2, 2021.
Poulton's colleagues
We found five more compensation records of executives who worked with Jeffrey V. Poulton at Alnylam Pharmaceuticals in 2019.
2019
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2019
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2019
Barry Greene
Alnylam Pharmaceuticals
Former President
2019
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2019
Laurie Keating
Alnylam Pharmaceuticals